1513 — Livzon Pharmaceutical Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapSuper Stock

Annual balance sheet for Livzon Pharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	CAS	CAS	CAS	CAS	CAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	8,871	9,978	9,328	10,518	11,403
Net Total Accounts Receivable
Net Total Receivables	2,532	2,998	3,379	4,110	3,655
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	12,873	14,627	14,673	16,987	17,266
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3,638	3,948	4,563	4,778	4,734
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	17,976	20,591	22,372	24,868	25,045
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	5,294	6,083	6,925	7,397	8,087
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	6,810	8,484	9,368	10,992	11,002
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	11,167	12,107	13,004	13,876	14,042
Total Liabilities & Shareholders' Equity	17,976	20,591	22,372	24,868	25,045
Total Common Shares Outstanding